← Markets

CorVel Corporation

CRVL · NASDAQ

Market closed$61.70$-0.550000 (-0.88%)After hours $61.70 · 0.00%

Key statistics

Previous close$62.25
Open$63.06
Day high$64.00
Day low$60.96
52-week high$97.97
52-week low$44.83
Market cap3.15B
Volume151.19K
Average volume215.92K
P/E ratio28.83
Forward P/E—
EPS2.14
Dividend yield0.00%

Market context

Why it moved

CRVL experienced a modest decline today amid neutral market sentiment and no clear positive catalysts, with technical analysis indicating a prevailing weak bias and absence of strong price positioning signals.

KucoinStocktradersdailyOptionchartsLinkedinFacebook

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026CorVel Corporation closed modestly lower, pulling back from recent technical gains after crossing above its 200-day moving average earlier this week — a notable milestone given the stock's 200-day average sits at $58.80. Analyst sentiment remains mixed, with a consensus 'Sell' rating despite a recent Wall Street Zen upgrade to 'Buy,' and insider selling adding to caution. The broader financial services sector faced headwinds as tech-driven market weakness and escalating U.S.-Iran tensions weighed on sentiment, though insurance peers like UnitedHealth surged on strong Q2 earnings, highlighting the selective nature of gains within the space.

-0.8835

July 17, 2026CorVel Corporation edged up modestly in regular trading before extending gains in after-hours, as the technology-driven workers' compensation and risk management firm builds on a key technical breakout above its 200-day moving average achieved earlier this week. The broader financial services sector is near 52-week highs, providing a supportive backdrop, while insurance brokers as a group have averaged 15.9% gains since their latest earnings results. Analyst sentiment on CRVL remains mixed — Wall Street Zen recently upgraded shares to 'buy' while Weiss Ratings maintains a 'sell' — and insider selling activity has drawn some investor attention ahead of the company's next earnings catalyst.

0.5167

July 15, 2026CorVel Corporation closed essentially flat, edging down fractionally in a session highlighted by the stock crossing above its 200-day moving average for the first time in recent months, reaching an intraday high of $62.73 before settling near its prior close. The technical milestone — with CRVL now trading above both its 50-day ($60.56) and 200-day ($58.80) moving averages — drew attention despite mixed analyst sentiment, including a 'sell' consensus from MarketBeat and a recent upgrade to 'buy' from Wall Street Zen. The broader financial sector (XLF) approached 52-week highs amid a favorable CPI report and strong Q2 bank earnings, providing a constructive backdrop for insurance-related names.

-0.2416

July 14, 2026CorVel Corporation shares closed down nearly 2%, underperforming the broader financial services sector as macro headwinds weighed on the stock. A cooler-than-expected June CPI print (3.5%) and strong Q2 bank earnings helped stabilize the broader market intraday, but CorVel gave back gains alongside the XLF, which also slipped in after-hours trading. The insurance brokerage industry is navigating a transitional environment, with commercial premiums softening after a 33-quarter streak of increases ended in Q1 2026, potentially pressuring fee-based revenue growth for managed care and risk management service providers like CorVel.

-1.8808

July 14, 2026CorVel Corporation closed modestly higher, outperforming a broader market that retreated amid renewed U.S.-Iran military tensions that sent oil prices surging and weighed on chip stocks. The financial services sector held up relatively well against the macro headwinds, with investors rotating toward more defensive names ahead of a pivotal Q2 earnings week. Recent insider disclosures revealed new CEO Sarah Scott holds stock options with exercise prices ranging from $49.63 to $110.18, reflecting performance-linked vesting tied to earnings growth criteria — a structure investors may view as aligning leadership incentives with long-term value creation.

1.5733

July 9, 2026CorVel Corporation closed modestly lower, edging down alongside a mixed financial services sector as geopolitical tensions from renewed U.S.-Iran strikes and oil price volatility weighed on broader market sentiment. The session's key company-specific development was CorVel's recognition as a 2026 PropertyCasualty360 Insurance Luminaries winner for Excellence in Claims Management, highlighting its integrated CareMC platform and AI-driven approach to risk management. The award arrives as peers in the insurance brokerage space face valuation headwinds — Wolfe Research downgraded Arthur J. Gallagher on full valuation, while Morgan Stanley cut Brown & Brown on organic growth concerns — potentially reinforcing CorVel's differentiated positioning as a technology-forward claims solutions provider.

-0.3651

July 9, 2026CorVel Corporation fell roughly 2% on Wednesday, pressured by a broad market risk-off selloff after President Trump declared the U.S.-Iran ceasefire 'over,' sending oil prices surging and dragging down financial and insurance sector stocks — the XLF financials ETF also closed lower on elevated volume. The decline overshadowed a positive company development: CorVel was named a 2026 PropertyCasualty360 Insurance Luminaries winner for Excellence in Claims Management, recognizing its CareMC platform and integrated clinical approach. In after-hours trading, shares recovered, edging back up roughly 1.75% toward $64.10.

-2.0675

June 30, 2026CorVel Corporation closed up modestly on the final trading day of the first half of 2026, aided by the launch of Marketwise Repricing — a new market-based medical bill repricing tool targeting complex, high-variance, and out-of-network billing scenarios. The product debut drew investor attention to valuation questions, with CorVel trading at a P/E of 28.3x, well below its peer average of 96.3x, and a DCF-implied fair value of ~$97 per share versus the current price — even as its 1-year total shareholder return remains down roughly 41%.

1.4112

Simply Wall Street · July 9, 2026Is CorVel (CRVL) Cheap Following Its Claims Management Award?www.marketscreener.com · July 8, 2026CorVel Named 2026 PropertyCasualty360 Insurance Luminaries Winner for Excellence in Claims ManagementQuiver Quantitative · July 8, 2026CorVel Corporation Named 2026 PropertyCasualty360 Insurance Luminaries Winner in Excellence in Claims ManagementPluang · July 8, 2026CorVel wins 2026 Insurance Luminaries award for excellence in claims management.Stock Titan · June 17, 2026CorVel’s new pricing tool tackles uneven medical bills across statesInvesting.com Nigeria · June 10, 2026Corvel Corp director Michael Jeffrey J. sells $548,834 of shares By Investing.comGlobeNewswire · June 2, 2026CorVel Marks 35 Years on Nasdaq, Signals Next Phase of Long-Term Innovation and GrowthGlobeNewswire · June 1, 2026CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair
Benzinga · June 17, 2026CorVel Launches CorVel Marketwise Repricing To Enhance Cost Containment
Mt Newswire · June 11, 2026Corvel Insider Sold Shares Worth $1,279,739, According to a Recent SEC Filing
Mt Newswire · June 10, 2026Corvel Insider Sold Shares Worth $548,834, According to a Recent SEC Filing
Mt Newswire · June 9, 2026Corvel Insider Sold Shares Worth $421,558, According to a Recent SEC Filing
Mt Newswire · June 1, 2026CorVel Appoints Sarah Scott as CEO
Benzinga · June 1, 2026CorVel Appoints Sarah Scott President, CEO, Effective July 1, Succeeding Michael G. Combs, Who Is Named Executive Chair
Benzinga · May 20, 2026CorVel Q4 2026 Earnings Call: Complete Transcript
Mt Newswire · May 20, 2026CorVel Fiscal Q4 Earnings, Revenue Rise

Peers

S&P 500SPX · $7,457.69-1.01%Chemed CorporationCHE · $510.03+1.70%Pediatrix Medical Group, Inc.MD · $26.13-0.80%AMN Healthcare Services, Inc.AMN · $35.00+2.28%Cross Country Healthcare, Inc.CCRN · $13.240.00%Option Care Health, Inc.OPCH · $21.74-1.63%Privia Health Group, Inc.PRVA · $26.90-1.18%Addus HomeCare CorporationADUS · $114.52+0.62%RadNet, Inc.RDNT · $62.19-1.27%Willis Towers Watson Public Limited CompanyWTW · $293.43-0.31%Goosehead Insurance, IncGSHD · $54.28-1.61%The Baldwin Insurance Group, Inc.BWIN · $27.25-0.91%